Abstract
This study aimed to analyze the expression, clinical significance of proto-oncogene in nasopharyngeal carcinoma and the biological effect in its cell line by siRNA targeting wild-type p53-induced phosphatase 1 (Wip1). Immunohistochemistry and western blot were respectively used to analyze Wip1 protein expression in 85 cases of nasopharyngeal cancer and normal tissues to study the relationship between Wip1 expression and clinical factors. Wip1 siRNA was transiently transfected into papillary nasopharyngeal carcinoma cell by liposome-mediated method and was detected by Quantitative real-time RT-PCR (qRT-PCR) and western blot. MTT assay, cell apoptosis, migration and invasion were also conducted as to the influence of the down-regulated expression of Wip1 that might be found on CNE2 cells biological effect. The level of Wip1 protein expression was found to be significantly higher in nasopharyngeal cancer tissue than normal tissues (P <0.05). There were significant differences between Wip1 expression and T stages, lymph node metastasis, clinical stages, tumor differentiation and radiotherapy response (P < 0.05), regardless of age, gender (P > 0.05). Meanwhile, Increased expression of Wip1 was significantly with poor overall survival time by Kaplan-Meier analysis (P < 0.05). Wip1 expression deletion determines independent risk factors for prognosis of patients with nasopharyngeal carcinoma in addition to tumor T stage, clinical stage, histological grade and lymph node metastasis outside by Cox-2 in the regression analysis (P < 0.05). qRT-PCR and Western blot showed that CNE2 cell transfected Wip1 siRNA had a lower relative expressive content than normal cell (P < 0.05). MTT assay, cell apoptosis, cell cycles demonstrated that CNE2 cell transfected Wip1 siRNA had a lower survival fraction, higher cell apoptosis, more percentage of the G0/G1 phases, significant decrease in migration and invasion, and higher P53 and P16 protein expression compared with CNE2 cell untransfected Wip1 siRNA (P < 0.05). Wip1 protein was increased in nasopharyngeal carcinoma, specifically in T stages, lymph node metastasis, clinical stages and tumor differentiation. Wip1 may involved in the biological processes of nasopharyngeal cancer cell proliferation, apoptosis, and migration and invasion by regulation P53 and P16 protein expression.
Similar content being viewed by others
References
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010:a systematic analysisfor the global burden of disease study 2010. Lancet 380(9859):2095–128
Wei WI, Sham JS (2005) Nasopharyngeal carcinoma. Lancet 365(9476):2041–2054
Chang ET, Adami HO (2006) The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 15(10):1765–1777
Lo KW, To KF, Huang DP (2004) Focus on nasopharyngeal carcinoma. Cancer Cell 5(5):423–428
Fuku T, Semba S, Yutori H, Yokozaki H (2007) Increased wild-type p53-induced phosphatase 1 (Wip1 or PPM1D) expression correlated with downregulation of checkpoint kinase 2 in human gastric carcinoma. Pathol Int 57(9):566–571
Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG (2000) New guidelines to evaluate the response to treatment in solid tumors. European organization for research and treatment of cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92(3):205–216
McCarty KS Jr, Szabo E, Flowers JL, Cox EB, Leight GS, Miller L, Konrath J, Soper JT, Budwit DA, Creasman WT (1986) Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors. Cancer Res 46(8 Suppl):4244s–4248s
Turashvili G, Bouchal J, Ehrmann J, Fridman E, Skarda J, Kolar Z (2007) Novel immunohistochemical markers for the differentiation of lobular and ductal invasive breast carcinomas. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 151(1):59–64
Rai-el-Balhaa G, Pellerin JL, Bodin G, Abdullah A, Hiron H (1985) Lymphoblastic transformation assay of sheep peripheral blood lymphocytes: a new rapid and easy-to-read technique. Comp Immunol Microbiol Infect Dis 8(3–4):311–318
Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C (1995) Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 184(1):39–51, A novel assay for apoptosis
Li J, Yang Y, Peng Y, Austin RJ, van Eyndhoven WG, Nguyen KC, Gabriele T, McCurrach ME, Marks JR, Hoey T, Lowe SW, Powers S (2002) Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23. Nat Genet 31(2):133–134
Saito-Ohara F, Imoto I, Inoue J, Inoue J, Hosoi H, Nakagawara A, Sugimoto T, Inazawa J (2003) PPM1D is a potential target for 17q gain in neuroblastoma. Cancer Res 63(8):1876–1883
Mendrzyk F, Radlwimmer B, Joos S, Kokocinski F, Benner A, Stange DE, Neben K, Fiegler H, Carter NP, Reifenberger G, Korshunov A, Lichter P (2005) enomic and protein expression profiling identifies CDK6 as novel in dependent prognostic marker in medulloblastoma. J Clin Oncol 23(34):8853–8862
Yang DH, He JA, Li J, Ma WF, Hu XH, Xin SJ, Duan ZQ (2010) Expression of proto-oncogene Wip1 in breast cancer and its clinical significance. Nat Med J Chin 90(8):519–522
Ling CH, Jiao BH, Lu SK, Guo EK, Zhang GY (2011) The Expression of proto-oncogene Wip1 in human glioblastoma multiforme and cell lines. Chin J Neurol Oncol 9(1):1–6
Ling CH, Jiao BH, Guo EK, Lu SK (2011) Over-expression of proto-oncogene Wip1 in intracranial ependymomas association with P53. Basic Clin Med 31(4):430–434
Yang DH, Zhang H, Hu XH, Xin SJ, Duan ZQ (2011) Abnormality of p16/p38MAPK/p53/Wip1 pathway in papillary thyroid cancer and its significance. Chin J Gen Surg 20(11):1199–1202
Oliva TM, Erthonaud BV, Chevalier A, Ducrot C, Marsolier-Kergoat MC, Mann C, Leteurtre F (2007) The Wip1 phosphatase (PPM1D) antagonizes activation of the Chk2 tumour suppressor kinase. Oncogene 26(10):1449–1458
Liao Q, Guo X, Li X, Xiong W, Li X, Yang J, Chen P, Zhang W, Yu H, Tang H, Deng M, Liang F, Wu M, Luo Z, Wang R, Zeng X, Zeng Z, Li G (2013) Prohibitin is an important biomarker for nasopharyngeal carcinoma progression and prognosis. Eur J Cancer Prev 22(1):68–76
Zhou JY, Chong VF, Khoo JB, Chan KL, Huang J (2007) The relationship between nasopharyngeal carcinoma tumor volume and TNM T- classification:a quantitativeanalysis. Eur Arch Otorhinolaryngol 264(2):169–174
Wu Z, Zeng RF, Su Y, Gu MF, Huang SM (2013) Prognostic significance of tumor volume in patients with nasopharyngeal carcinoma undergoing intensity-modulated radiation therapy. Head Neck 35(5):689–694
Wang P, Rao J, Yang HF, Zhao HY, Yang L (2010) Inhibitory effects of lentivirus mediated RNA interference targeting human Wip1 gene on the prolif-eration of human glioma U251 cells. Chin J Exp Surg 27(4):76–79
Baxter EW, Milner J (2010) p53 Regulates LIF expression in human medulloblastoma cells. J Neuro-Oncol 97(3):373–382
Lowe JM, Cha H, Yang Q, Fornace AJ Jr (2010) Nuclear factor- kappaB (NF-kappaB) is a novel positive transcriptional regulator of the oncogenic Wip1 phosphatase. J Biol Chem 285(8):5249–5257
Armstrong NJ, Fagotto F, Pthmann C, Rupp RA (2012) Maternal Wnt/β-catenin signaling coactivates transcription through NF-κB binding sites during Xenopus axis ormation. PLoS One 7(5):e36136
Pan H, Zhou W, He W, Liu X, Ding Q, Ling L, Zha X, Wang S (2012) Genistein inhibits MDA-MB-231 triple- negative breast cancer cell growth by inhibiting NF-kappaB activity via the Notch-1 pathway. Int J Mol Med 30(2):337–343
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sun, G.G., Zhang, J., Ma, X.B. et al. Overexpression of Wild-Type p53-Induced Phosphatase 1 Confers Poor Prognosis of Patients with Nasopharyngeal Carcinoma. Pathol. Oncol. Res. 21, 283–291 (2015). https://doi.org/10.1007/s12253-014-9819-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12253-014-9819-1